Declan Fox wrote:
> I quote this fascinating bit of neuro-transmitter research from some
> French journal, abstract on PubMed. It struck me because our health
> board prescribing advisers have tried to sink escitalopram, even going
> so far as the pre-emptive strike of directing us to prescribe it
> generically even though there won't be a generic along for a few years.
Prescribing it by drug name (and by isomer) seems a good idea,
regardless of the brands available.
The advisers are drug reps, really, but regulated less effectively.
Most of their output is spam.
--
A
|